RESEARCH-USE BIOSIMILAR ANTIBODY
Varlilumab
Monoclonal antibody · IgG1
Varlilumab (CDX-1127) is an agonist anti-CD27 monoclonal antibody. Varlilumab can promote T cell expansion and activate the immune response. Varlilumab has anti-tumor activity and can be used in the research of hematological malignancies and solid tumors.
TARGETCD27
YMonoclonal antibody
CATALOGSC-BS-052
CATALOG NUMBERSC-BS-052
MOLECULAR WEIGHTApprox. 145.58 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Varlilumab (CDX-1127) is an agonist anti-CD27 monoclonal antibody. Varlilumab can promote T cell expansion and activate the immune response. Varlilumab has anti-tumor activity and can be used in the research of hematological malignancies and solid tumors.
Varlilumab is a recombinant research-use antibody directed against CD27.